Publications by authors named "Julien Poupart"

Claim this Profile
S
Squaramide Formation for DNA-Encoded Library Synthesis.
Antoine Douchez, Julien Poupart, Gaoqiang Yang, Louis Vaillancourt, Anne Marinier

Bioconjug Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing the role of positivity bias, cognitive impairment and emotional reactivity in the deontological preference in multiple sclerosis during moral dilemmas: a social cognition study protocol.
Laurent Zikos, Béatrice Degraeve, Antonio Pinti, Julien Poupart, Laurène Norberciak

Front Psychol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, Bertrand Audoin, Xavier Ayrignac, Julien Poupart

Mult Scler· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligoclonal Band Straightening Based on Optimized Hierarchical Warping for Multiple Sclerosis Diagnosis.
Farah Haddad, Samuel Boudet, Laurent Peyrodie, Nicolas Vandenbroucke, Julien Poupart

Sensors (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
Helene Zephir, Julien Poupart, Romain Deschamps, Bertrand Audoin, Jonathan Ciron

Neurology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Céline Louapre, Nicolas Collongues, Bruno Stankoff, Claire Giannesini, Caroline Papeix, Julien Poupart

JAMA Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Julien Poupart, Jonathan Giovannelli, Romain Deschamps, Bertrand Audoin, Jonathan Ciron

Neurology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of -Dodecyl l-Peptide to Enhance Serum Stability while Maintaining Inhibitory Effects on Myometrial Contractions Ex Vivo.
Julien Poupart, Xin Hou, Sylvain Chemtob, William D Lubell

Molecules· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis